首页> 外国专利> 109 23 89 KNOCK-IN MOUSE HOMOLOGOUS RECOMBINATED BY BANK VOLE'S PRION PROTEIN GENE WHICH 109TH AMINO ACID IS METHIONINE AND FROM 23TH TO 89TH AMINO ACID CODING SEQUENCES ARE ELIMINATED AND APPLICATIONS THEREOF

109 23 89 KNOCK-IN MOUSE HOMOLOGOUS RECOMBINATED BY BANK VOLE'S PRION PROTEIN GENE WHICH 109TH AMINO ACID IS METHIONINE AND FROM 23TH TO 89TH AMINO ACID CODING SEQUENCES ARE ELIMINATED AND APPLICATIONS THEREOF

机译:109 23 89消除了109氨基酸为甲硫氨酸和23到89氨基酸编码序列的库尔氏G蛋白基因组成的敲入小鼠同源性及其应用

摘要

The present invention relates to a knock-in mouse homologous recombinated with a bank vole′s prion protein gene in which the 109th amino acid is methionine and a sequence encoding from the 23rd to the 89th amino acids is deleted; and an application of the same. More specifically, the present invention relates to a knock-in mouse whose inherent prion protein gene is knocked-in with a cellular prion protein gene of a bank vole in which the 109th amino acid is methionine and a sequence encoding from the 23rd to the 89th amino acids is deleted, by a homologous recombination method; and an application of the same. According to the present invention, a knock-in mouse may be produced whose inherent prion protein gene is replaced (substituted) with the gene of the prion protein of a bank vole in which the 109th amino acid is methionine and a sequence encoding from the 23rd to the 89th amino acids is deleted by a homologous recombination method, and the knock-in mouse thus produced may be used beneficially as an animal model used to evaluate the anti-prion validity of a candidate material of a drug developed to treat prion disease including CJD. Further, the present invention may be beneficially used in studies to identify a role in the emergence of prions or to improve the performance of an anti-prion material.
机译:本发明涉及与田鼠的病毒蛋白基因重组的敲入小鼠,其中基因的第109个氨基酸是甲硫氨酸,并且缺失了编码第23个至第89个氨基酸的序列。和相同的应用。更具体地,本发明涉及一种敲入小鼠,其固有inherent病毒蛋白基因与其中第109位氨基酸为甲硫氨酸的银行田鼠的细胞病毒蛋白基因和从23至89编码的序列敲入通过同源重组方法缺失氨基酸;和相同的应用。根据本发明,可以生产敲入小鼠,其固有inherent病毒蛋白基因被银行田鼠的pr病毒蛋白基因(其中第109个氨基酸是甲硫氨酸)和从第23位开始编码的序列替换(取代)。通过同源重组方法缺失第89位氨基酸到第89位氨基酸,并且由此产生的敲入小鼠可以有利地用作动物模型,用于评估开发用于治疗病毒疾病的药物的候选材料的抗pr病毒有效性,所述药物包括CJD。此外,本发明可以有利地用于研究中以鉴定在病毒出现中的作用或改善抗anti病毒材料的性能。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号